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AbstrACt
Introduction Poor road and communication infrastructure 
pose major challenges to tuberculosis (TB) control in many 
regions of the world. TB surveillance and patient support 
often fall to community health workers (CHWs) who may 
lack the time or knowledge needed for this work. To 
meet the End TB Strategy goal of reducing TB incidence 
by 90% by 2035, the WHO calls for intensified research 
and innovation including the rapid uptake of new tools, 
interventions and strategies. Technologies that ‘leapfrog’ 
infrastructure challenges and support CHWs in TB control 
responsibilities have the potential to dramatically change 
TB outcomes in remote regions. Such technologies may 
strengthen TB control activities within challenged national 
tuberculosis treatment and control programmes (NTPs), 
and be adapted to address other public health challenges. 
The deployment of innovative technologies needs to 
be differentially adapted to context-specific factors. 
The Drone Observed Therapy System (DrOTS) project 
was launched in Madagascar in 2017 and integrates a 
bundle of innovative technologies including drones, digital 
adherence monitoring technology and mobile device-
based educational videos to support TB control.
Methods and analysis This mixed-methods study 
gathers and analyses cultural perceptions of the 
DrOTS project among key stakeholders: patients, 
community members, CHWs, village chiefs and NTP–
DrOTS mobile health teams. Data from questionnaires, 
semistructured interviews, focus group discussions 
(FGD) and ethnographic observation gathered from 
June 2018 to June 2019 are thematically analysed and 
compared to identify patterns and singularities in how 
DrOTS stakeholders perceive and interact with DrOTS 
technologies, its enrolment processes, objectives and 
team.
Ethics and dissemination Ethics approval was obtained 
from the National Bioethics Research Committee of 
Madagascar and Stony Brook University institutional 
review board. Study results will be submitted for peer-
reviewed publication. In Madagascar, results will be 
presented in person to Ministry and other Malagasy 
decision-makers through the Institut Pasteur de 
Madagascar.
Patient and public involvement This study is designed 
to foreground the voices of patients and potential patients 
in the DrOTS programme. CHW participants in this study 
also supported the design of study information sessions 
and recruitment strategies. One member of the mobile 
health team provided detailed input on the wording and 
content of FGD and interview guides. Study findings will 
be presented via a report in French and Malagasy to CHW, 
mobile health team and other village-level participants 
who have email/internet access.
strengths and limitations of this study
 ► This study is one of the first to assess acceptance 
and perceptions of drones and evriMED pillboxes 
(medication reminder and digital remote treat-
ment adherence monitoring devices), technologies 
currently being considered for scale-up in several 
health systems around the world. The bundle of 
technologies at the core of this study is one that 
could be applied in response to other health needs 
in other contexts.
 ► Qualitative methods facilitate detailed and nuanced 
understanding of how and why stakeholders with 
limited literacy and in remote settings perceive and 
use new technologies.
 ► Data are collected from a range of stakeholders and 
focused on those using these new technologies on 
the front-lines in low-income countries (ie, patients, 
national mobile healthcare team members, commu-
nity health workers and villagers).
 ► Findings from perception studies serve to deepen 
understanding of how contextual particularities can 
impact on acceptance, perceptions of and interac-
tions with new technologies but may not be gen-
eralisable across distinct settings and populations.
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IntroduCtIon
Ten million people developed active tuberculosis (TB) 
disease in 2017.1 To meet the End TB Strategy goal of 
reducing incidence by 90% and mortality by 95% before 
2035, the WHO has called for intensified research and 
innovation including the rapid uptake of new tools, inter-
ventions and strategies.2 In low-income and middle-in-
come countries (LMIC) that are disproportionately more 
affected by disease, TB control can be hindered by any 
number of social and structural factors, including limited 
access to centralised facilities for populations living outside 
the capital, understaffed healthcare infrastructures, poor 
development of laboratory diagnostic networks or stigma 
influencing healthcare seeking behaviours and treatment 
adherence.3 4 In such contexts, diagnosis may be delayed 
or fail to occur at all, and implementation of TB control 
essential strategies such as case finding, access to labo-
ratory diagnosis, directly observed therapy and contact 
tracing by national tuberculosis control programmes 
(NTPs) becomes particularly challenging, increasing 
secondary transmission and fatalities.5 
In 2017, nearly 30 000 TB cases were reported in Mada-
gascar.6 This corresponds to half of actual cases to have 
occurred in the country, as estimated by WHO.6 Treatment 
adherence and success rates are reported to be highly 
variable between regions of the country, respectively, 
averaging 60% and 84% in the Drone Observed Therapy 
System (DrOTS) intervention area and at national level.6 7 
Madagascar exemplifies the challenges of quality TB care 
delivery for remote and dispersed populations as 40% of 
Malagasy people live more than 5 km from the nearest 
basic healthcare facility, with no public transit system or 
even roads in many cases.8 TB diagnosis and treatment 
challenges in Madagascar are representative of those in 
many areas of sub-Saharan Africa: (i) underserved health-
care system; (ii) poverty and cultural norms hindering 
healthcare seeking; (iii) paucity of human resource 
capacities with training in TB; (iv) paucity of diagnostic 
facilities; (v) suboptimal coverage of treatment and treat-
ment follow-up and (vi) high prevalence of two important 
TB risk factors, that is, malnutrition and indoor air pollu-
tion.5 7 9 10 Conversely, factors of good prognosis for TB 
control in Madagascar include very low rates of both 
multi-drug resistant TB (MDR-TB) infection and HIV-TB 
coinfection in the country.6 11
To leapfrog over theses impediments to quality TB care, 
the DrOTS project was coinitiated with the Malagasy NTP 
and was deployed by Stony Brook University’s Global 
Health Institute in collaboration with the Institut Pasteur 
de Madagascar. The project was implemented in 61 
randomly selected villages in Androrangavola commune, 
south-eastern Madagascar, in August 2017. Up to 70% 
of the approximately 27 000 inhabitants living in Andro-
rangavola commune live more than 5 km away from the 
closest healthcare facility, and that facility in turn is situ-
ated more than 1 day’s walk from the closest TB diagnosis 
centre.12 DrOTS involves an NTP–DrOTS mobile health 
team consisting of TB nurses and doctors who collaborate 
with local community health workers (CHWs). DrOTS 
implements active case finding and supports TB 
screening, diagnosis, counselling and treatment super-
vision within communities using a suite of technologies: 
drones, evriMED pillboxes and tablet-based educational 
videos. In this scheme, drones increase access to diagnosis 
and care by facilitating specimen transport and securing 
the medication supply chain between diagnosis and treat-
ment centres and remote communities; the evriMED 
supports TB treatment adherence and monitoring by 
beeping when patients need to take their medication, 
and tracking for healthcare providers when the evriMED 
has been opened (equated with dose being taken); and a 
tablet-based eHealth video curriculum supports patients 
and CHWs by providing key information on TB care and 
prevention at every step of the pathway to cure. Given 
the novelty of this approach, we designed and presented 
here a study protocol for the DrOTS perception study, a 
mixed-method cultural acceptability substudy embedded 
within the DrOTS project.
Several organisations are exploring the economic 
and practical feasibility of using drones for healthcare 
purposes including support to rescue missions in disas-
ters; enhanced epidemiological monitoring for disease 
outbreaks and vectors; delivery of critical resources such 
as blood or defibrillators in emergencies; delivery of other 
routine and occasional medical payloads such as samples 
for laboratory analysis, vaccines, medication and supplies 
for community healthcare centres.13–18 Medication 
reminder and remote treatment adherence monitoring 
devices, such as the evriMED pillbox, may augment treat-
ment adherence and facilitate more effective allocation 
of limited healthcare personnel resources in contexts 
where populations are hard to reach, or health systems 
under-resourced.19–21 While the potential of new digital 
technologies to transform healthcare is enormous, this 
potential is contingent on user-specific and context-spe-
cific needs, engagements with technologies and digital 
health strategies, and may imply different impacts and 
challenges in different contexts.22
This study will shed light on cultural and individual 
perceptions, barriers and facilitators to implementa-
tion of the unique bundle of technologies that make up 
the DrOTS system. To facilitate the implementation of 
such innovative technologies, other challenges such as 
sustained funding, creation of an LMIC-friendly market 
environment for drone supplies and aviation regulation 
approval also need to be overcome: such barriers are not 
addressed here.
rationale
Determining the success of the DrOTS project cannot 
be limited to evaluation of its impacts on additional TB 
notifications or completed treatments. Though such 
measures are central to establishing the value and poten-
tial of innovative technologies in the global fight against 
TB, the success of innovative public health strategies is 
also contingent on how those on the receiving end of 
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these perceive and engage with its objectives, enrolment, 
participation processes and technologies. The DrOTS 
perception study aims to build expertise on how to 
implement new technologies in a way that is acceptable 
to individuals and communities that lack close or afford-
able access to TB diagnosis and treatment, have no prior 
exposure to such technologies and may harbour under-
standings of TB that limit management of presumptive 
or confirmed infections. Attending to these contextual 
and lived particularities of the DrOTS project is key to 
designing and planning feasible and effective scale-up. 
Recently published WHO guidelines will certainly help 
TB control programmes choosing and implementing 
digital adherences monitoring technologies.22 At present, 
there exists no ethical or practical guidance on the 
contextually sensitive use of such technologies or for the 
use of drones for disease diagnosis and treatment. This 
study can inform needed evidence-based guidance for 
the future expansion of such technology suites poised to 
strengthen TB programmes and healthcare systems more 
generally.
Primary objectives
1. To identify prevalent perceptions (eg, perceived ben-
efits, concerns, misunderstandings) related to the var-
ious technological and programmatic aspects of the 
DrOTS project at the level of TB patients, members 
of patient households, other village members, CHWs, 
village chiefs and NTP–DrOTS mobile health team.
2. To generate a description of how and why individuals, 
families and villages are interacting with specific com-
ponents of the DrOTS project in unanticipated ways.
secondary objectives
1. To establish rates and demographic distribution of 
understandings of and interactions with the various 
technological and programmatic aspects of the DrOTS 
project.
2. To generate understandings of how and based on what 
factors individuals, families and villages are deciding 
whether or not to participate in the DrOTS project.
3. To develop a set of evidence-based cultural and con-
textual considerations that can inform the implemen-
tation of similar technology-mediated diagnostic and 
treatment in other regions of Madagascar and in other 
national contexts.
MEthods And AnAlysIs
study design
The DrOTS perception study is a mixed-methods study 
involving cross-sectional data collection through (i) 
questionnaires (~750), (ii) focus group discussions 
FGDs (~19), (iii) semistructured in-depth interviews 
(~24) and (iv) ethnographic observation (figure 1). 
Quantitative questionnaire data are collected throughout 
the DrOTS project period (November 2017–December 
2018) as well as an additional 6-month after project end 
for follow-up of TB patients adhering to a 6-month treat-
ment regimen. Data collection for the qualitative part is 
initiated in June 2018 with a first village visit, followed by 
second and third village in August and November 2018, 
respectively. Ethnographic observation occurs between 
June and July 2018. All study tools were developed by 
content experts in dialogue with members of the DrOTS 
Figure 1 Timelines, approaches and tools, DrOTS perception study, Madagascar, 2017–2019. DrOTS, Drone Observed 
Therapy System; TB, tuberculosis. 
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team responsible for community engagement and/or 
familiar with local dialect and customs in Androrangavola 
commune.
Questionnaire survey
The use of the questionnaire survey in this mixed-methods 
study aims to support measurement and comparison 
of key acceptability indicators between different study 
subgroups (eg, patients vs non-patients, most educated 
vs least educated). The questionnaire is being adminis-
tered to different groups including patients, members of 
patient households, other village members, CHWs, village 
chiefs and NTP–DrOTS mobile health teams.
Two questionnaires are being used: (i) DrOTS baseline 
questionnaire conducted with presumptive and confirmed 
TB cases, other village members and CHWs (see online 
supplementary material 1—DrOTS Perception Study 
Baseline Questionnaire), and (ii) DrOTS end-of-treat-
ment questionnaire conducted with confirmed TB 
cases (see online supplementary material 2—DrOTS 
Perception Study End-of-Treatment Questionnaire). 
Questionnaires are administered verbally by members 
of the NTP–DrOTS mobile health team to 10–15 individ-
uals aged ≥15 years in each of the DrOTS-participating 
villages, amounting to a total of around 750 completed 
baseline questionnaires. The sample size was calculated 
based on (i) a total population size of 27 000 in Andro-
rangavola commune, (ii) on the assumption that 50% 
reply ‘Yes’ to one main question on drone perception (ie, 
‘Do you think that the drones bring something positive to 
your community?’, (iii) a 95% confidence level and (iv) a 
10% drop-out rate. This resulted in a sample size of 417. 
However, the overall DrOTS-project design, lifespan and 
geographic coverage allowed us to sample a larger popu-
lation. All self-presenting presumptive (including later 
confirmed) TB cases and CHWs are purposively invited 
to answer the baseline questionnaire, with remaining 
participants being randomly recruited in each DrOTS 
village. This questionnaire provides quantitative data on 
basic sociodemographic characteristics, travel history, TB 
risk factors, TB-related health seeking behaviour, medical 
history, knowledge on TB and behaviours towards TB. 
An end-of-treatment questionnaire is administered to all 
enrolled TB patients on completion of treatment. This 
questionnaire addresses specific perceptions of drones, 
evriMED and educational videos. Questionnaire data are 
collected using tablet-based Open Data Kit (ODK) soft-
ware standardised form.
Focus group discussions
FGD-based qualitative data collection is taking place in 
three of the 61 DrOTS participating villages as well as 
with the NTP–DrOTS mobile health team. Villages for 
the running of FGDs are selected based on1 participation 
in the DrOTS project for at least 3 months2; accessibility 
for the qualitative research team, meaning within a day’s 
hike from the closest vehicle-accessible town3 and will-
ingness to host the DrOTS perception team. Collecting 
data in three villages enables comparison of reported 
perceptions and acceptability of new technologies across 
villages, the possibility for diversity in perceptions to be 
captured. Furthermore, even where similarities exist, a 
more nuanced understanding of how village-specific char-
acteristics, such as access to livelihood activities, norms of 
postsecondary education achievement and historical rela-
tions to outsiders travelling in the region (eg, for mining 
or development initiatives) may shape perceptions of the 
DrOTS project.
Sampling of FGD participants is purposive and 
randomised. It is purposive inasmuch as we are aiming 
to gather perceptions from a range of individuals who 
have engaged with DrOTS first-hand. For FGDs, we also 
aim to have an equal representation of men and women, 
and an equal representation across age groups in villages, 
towards capturing potential diversity in experiences of 
DrOTS based on diverse levels or types of responsibility 
in the home and village. Villagers willing to partake in 
a FGD provide their names to the research team, and 
may or may not be randomly selected to join the FGD 
organised for their age and gender group. Randomised 
selection of village FGD participants avoids burdening 
CHWs or other leaders with the task of identifying poten-
tial participants (which could also potentially result in 
biased responses tied to particular village interests). Also, 
in our experience, many are interested in participating 
in FGDs, and this randomised selection ensures all those 
interested have and know they have an equal chance of 
being selected (names of volunteers drawn from hat at 
village meeting).
Homosociality and age-group separation are domi-
nant norms guiding social interaction in this part of 
Madagascar. Hence, to facilitate participants feeling at 
ease and to limit the possibility of social hierarchies in 
a FGD over-determining who feels able to express their 
view in a group, FGDs are being organised along age and 
gender lines: married men, married women, unmarried 
men, unmarried women, elder men and elder women 
(table 1). FGDs are run using a standard set of questions 
organised into two parts. Part I focuses on deepening 
the understanding of the participants’ day-to-day defini-
tion and management of illness and understandings of 
TB prior to DrOTS and part II focuses on perceptions 
and interactions with DrOTS. The set of questions for 
the NTP–DrOTS mobile health team FGD is distinct, and 
probes members’ understanding and concerns related to 
DrOTS, as well as perceptions of cultural and village-spe-
cific attitudes, knowledge and engagements with specific 
aspects of DrOTS pilot project based on work in all 
villages (see online supplementary material 3—DrOTS 
Perception Study FGD Guide). All FGDs are moderated 
and/or supervised by an experienced medical anthro-
pologist and conducted in Malagasy local dialect with the 
help of a translator. With participants’ permission, these 
are digitally recorded.
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Semistructured in-depth interviews
Semistructured in-depth interviews gather informa-
tion on different stakeholders’ knowledge of, attitudes 
towards, uses and first-hand experiences of the DrOTS 
project that cannot be gleaned from questionnaires, 
and may be too sensitive or detailed to emerge in FGDs 
(online supplementary material 4—DrOTS Perception 
Study SemiStructured Interview Guide). Recruitment 
is purposive and targets five categories of key stake-
holders in each village 1) DrOTS project-enrolled adult 
patients (over 15 years of age) 2) adults who presented 
for TB testing to the DrOTS team but have received nega-
tive diagnostic testing results 3) villagers hesitant, unable 
or have declined to join the project 4) CHWs 5) village 
leaders, including kings and elected district chiefs. All 
participants except for participants from category 3 are 
being identified with help from the NTP–DrOTS mobile 
team. Participants in category 3 are invited to self-identify 
in the process of FGDs and may be identified by other 
interview participants using ‘snowball sampling’. An esti-
mated eight interviews will be performed in the same 
subset of three villages as FGDs for a total of 24 interviews 
(table 2). Additional interviews are performed with TB 
confirmed cases outside the included villages to increase 
the number of DrOTS-enrolled patients.
Ethnographic observation
An anthropology trainee will seek permission to stay with 
one DrOTS patient in their village over a 2-week period 
in order to better understand, through ethnographic 
observation, how that individual lives with TB disease on 
a daily basis and interacts with DrOTS. The trainee will 
keep a record of what they notice and learn (field notes), 
attending to 1) ways in which patients, villagers, village 
leaders, the CHW in the village, or any members of the 
mobile health team present in this 2-week period discuss 
DrOTS with the patient or one another, 2) technical, 
practical community or individual level challenges, 3) any 
differences or similarities in attitudes or beliefs about the 
DrOTS pilot project study expressed in informal conver-
sation about the project and/or its technologies and 4) 
contextualised information about how the patient at the 
centre of this observation views and uses DrOTS tech-
nologies. Ethnographic observation often occurs over a 
period of months or even years; however, even shorter 
applications of this method can build contextual under-
standing of healthcare projects. Use of this method in 
this study may confirm or reveal gaps in the information 
gathered through the other data collection methods, and 
serve to identify questions for future research.
Analysis
Questionnaire quantitative data will be descriptively anal-
ysed using STATA V.14.0 (StataCorp; Texas, USA) and 
will address and compare levels of acceptability between 
groups.
Interviews and FGDs will be transcribed and trans-
lated into English by a professional Malagasy translator 
mastering the field study site local dialect. Transcripts 
will be uploaded into Nvivo V.12.0 (QSR; Melbourne, 
Australia) and be subjected to thematic analysis. Catego-
ries of enquiry in interview and FGD guides will form the 
basis for an initial coding structure. Three semistructured 
interviews will then be independently coded by two inves-
tigators to test and adjust this structure in light of the data, 
Table 1 Focus group discussion recruitment plan, DrOTS 
perception study, Madagascar, 2017–2019
Location Stakeholder group
Target 
no 
groups
Participants/
group
Village 1 Unmarried women 1 4
Unmarried men 1 4
Married women 1 4
Married men 1 4
Elderly women 1 4
Elderly men 1 4
Village 2 Unmarried women 1 4
Unmarried men 1 4
Married women 1 4
Married men 1 4
Elderly women 1 4
Elderly men 1 4
Village 3 Unmarried women 1 4
Unmarried men 1 4
Married women 1 4
Married men 1 4
Elderly women 1 4
Elderly men 1 4
National TB 
Programme
Mobile health unit 
team members
1 5
Total 19 77
DrOTS, Drone Observed Therapy System; TB, tuberculosis.
Table 2 Semistructured interview recruitment plan, DrOTS 
perception study, Madagascar, 2017–2019
Location Stakeholder group Participants
Sample village DrOTS enrolled patient 2
Villagers who tested 
negative for TB
2
Villagers hesitant, unable or 
who have declined DrOTS 
participation
2
Community health worker 1
Village leaders 1
Total 8
DrOTS, Drone Observed Therapy System; TB, tuberculosis. 
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adding themes to account for unanticipated but relevant 
content. In an iterative process, minor adjustments and 
additions (eg, change in theme names or merging of 
themes) to the codebook will be made when needed. Key 
theme and subtheme contents will be summarised and 
reviewed to allow linkage of quantitative and qualitative 
data, clearly identify themes with exemplary quotes, raise 
questions and concerns, and inform guidelines for cultur-
ally and contextually sensitive technology implemen-
tations. Ethnographic field notes will not be coded but 
will inform the analysis by providing support to findings 
from the interviews and FGDs, and/or by identifying gaps 
knowledge gaps.
dIssEMInAtIon
Following project and technology sensitisation visits and 
in accordance with cultural norms, consent is obtained 
from the local leaders to present this research project to 
villagers under their responsibility before engaging in 
any activities within villages. Though limited literacy is 
widespread in this region of Madagascar, as per national 
research ethics norm, consent forms are read and 
explained to participants and written informed consent 
is obtained from any and all parties agreeing to partic-
ipate before conducting interviews, focus groups and 
observations. Data are being anonymised rendering 
participants’ identification from dissemination material 
impossible. Participants in this perceptions study do not 
face any different healthcare as a result of participation. 
All patients diagnosed with TB within the DrOTS projects 
are treated for free in accordance with NTP and WHO 
guidelines.
One issue that requires managing in such a study is the 
risk of social stigma for participants. TB and association 
with TB are stigmatised in contexts around the world, and 
well documented in sub-Saharan Africa (eg,3 4 23–25 While 
there is no evidence of TB stigma in the Malagasy context 
of our research, we are adopting strategies to mitigate the 
risk of TB-related stigma developing for participants in 
our TB-focused study. In our initial meeting with CHWs 
in each village, we are stressing our interest in speaking 
with DrOTS-enrolled patients (TB active) but also our 
commitment to keeping the TB-active status of these 
patients private. We will be working with CHWs in villages 
to identify strategies to protect the TB-active status of any 
patients we interview. In presenting the study to the entire 
village, we are stressing our interest in understanding the 
villagers’—and not just presumptive or confirmed TB posi-
tive individuals’—perceptions of the DrOTS programme. 
The number of individuals, including respected elders, 
and range of visible healthiness of those who are partic-
ipating in either an interview or FGD in each village 
does reduce the possibility of a single individual among 
a village’s participants being associated with TB. We will 
not carry out the ethnographic observation component 
of this study if doing so risks rendering public a currently 
private TB diagnosis.
Results of the DrOTS perception study will be submitted 
for peer-review publication. A two-page summary of results 
will be prepared in French and Malagasy and included 
as an appendix to the results paper, and shared with 
participants and collaborators for whom we have contact 
information. In Madagascar, results will be presented in 
person to Ministry and other Malagasy decision-makers 
through the Institut Pasteur de Madagascar.
dIsCussIon
This study responds to a current gap in knowledge on the 
feasibility and cultural acceptability of using a new suite of 
technologies including evriMED, drones and tablet-medi-
ated video education to support improved TB diagnosis 
and treatment in remote populations. Digital technolo-
gies that enable remote monitoring and faster delivery of 
medical care and supplies are potential game changers 
for healthcare landscapes struggling with long-standing 
or temporary (eg, due to disasters) barriers to healthcare 
delivery. Still, the development of innovative healthcare 
technologies does not guarantee their enthusiastic and 
rapid adoption in diverse settings.26–28 Perceived benefits 
and risks, use and challenges of adopting such innovation 
is not likely to be uniform across distinct sociocultural, 
health system and economic settings. These may vary 
depending on any number of factors, including (to name 
just a few) the presence or lack of alternative options for 
care, association of use with a context-specific stigmatised 
condition, as well as prior direct or rumoured experi-
ences with interventions deemed to be similar in some 
way to the new ones. There is inherent ethical complexity 
in using devices such as drones for ‘surgical strikes’ on 
‘wicked’ global health challenges, if key determinants 
of poor health remain unaddressed.29 Recent studies 
conducted with intended users and ‘beneficiaries’ of 
new digital health systems in LMIC contexts reveal other 
context-specific and culture-specific concerns or limita-
tions of these technologies, such as concerns these could 
dehumanise assistance,28 infringe on private spaces30 and 
be too expensive for some governments.30 Findings from 
the DrOTS cultural acceptability study may or may not 
reveal similar concerns in the Malagasy context, and will 
be situated within growing literature on perceptions and 
acceptability of TB remote digital medical monitoring 
and adherence strategies.
While focused on one project in Madagascar, the 
DrOTS perception study provides a model for attending 
to contextual factors that may affect target population 
support and intended interactions with any number of 
other new public health initiatives around the world. 
Embedding such perception studies within projects is 
particularly important for initiatives conceptualised based 
on the theoretical but as of yet unproven potential of new 
technologies. While findings from perceptions studies on 
new innovative technology-mediated health projects may 
not be readily generalisable, as each setting is unique, 
such studies can generate learning that is transferable to 
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other settings by drawing attention to the range of factors 
that may impact on technology adoption and interac-
tion, and by shedding light on how others on the front 
line of innovative projects have sensitively navigated 
the cultural, social, political and ethical complexities 
of particular contexts. In these ways, perception studies 
that ‘localise’ understandings of how theoretically prom-
ising new technologies work in specific locales have an 
important role to play in informing evidence-based guid-
ance for context-sensitive implementation and scale-up of 
programmes such as DrOTS around the world.
limitations and potential challenges
The significance of results from this study will be difficult 
to ascertain given limited research on drone supported TB 
or other public health programmes at this juncture. Future 
research on similar programmes introduced in Madagascar 
or elsewhere will be helpful in assessing the generalisability 
of our eventual results to other regions and populations 
where such technologies for increased healthcare provision 
are being introduced. This study does not include inter-
views or FGDs with National TB programme policy-makers 
and decision-makers. Understanding rationales under-
lying government approval of pilot programmes such as 
DrOTS among individuals working for national TB control 
in the country, as well as the challenges and perception of 
outcomes and impact among these stakeholders constitute 
equally important research as we work towards clarifying 
what it means to develop context-appropriate use of inno-
vative technologies in TB control.
Respondents may overemphasise positive perceptions of 
DrOTS. Social desirability bias is a challenge in perceptions 
studies, especially where there may be unspoken assumption 
among participants that their responses to study questions 
could negatively impact future programmes.31 Our work 
across multiple villages will increase our ability to detect 
and probe overly positive accounts from participants. We 
are confident in the study’s design and its ability to generate 
accurate and detailed insight into perceptions of DrOTS; 
however, we recognise the possibility that with a focus on 
only three of the 61 DrOTS-enrolled villages, our qualitative 
data collection may not capture the full range of perceptions 
that may be present among Malagasy villagers enrolled in 
DrOTS.
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